Pursuant to the Regulation 30 read with Schedule III and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we hereby inform you that the Board of Directors of the Company at its Meeting held today i.e. 27th October, 2026 has inter-alia considered and approved the Unaudited Standalone and Consolidated Financial Results for the Quarter and Half Year Ended 30th September, 2026 along with the Limited Review ....

Date: 27th October, 2026 To To The Listing Department The Listing Department National Stock Exchange of India Limited Bombay Stock Exchange Limited Exchange Plaza, Floor 25, P. J. Towers, Bandra – Kurla Complex Dalal Street, Bandra (East) Mumbai – 400 001 Mumbai – 400 051 Stock Code : 532612 Stock Code : INDOCO Dear Sir/Madam, Subject: Outcome of Board Meeting held on 27th October, 2026 Pursuant to the Regulation 30 read with Schedule III and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we hereby inform you that the Board of Directors of the Company at its Meeting held today i.e. 27th October, 2026 has inter- alia considered and approved the Unaudited Standalone and Consolidated Financial Results for the Quarter and Half Year Ended 30th September, 2026 along with the Limited Review Report with unmodified opinion on the aforesaid Unaudited Financial Results. Please find enclosed copies of the following: 1. Unaudited Standalone and Consolidated Financial Results for the Quarter and Half Year Ended 30th September, 2026 as per Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 2. Limited Review Report with unmodified opinion issued by our Statutory Auditors M/s. Gokhale & Sathe, Chartered Accountants. 3. Press Release. The Board Meeting commenced today at 11:20 a.m. and concluded at 12:40 p.m. You are requested to kindly take the same on record. Thanking you, Yours faithfully, For Indoco Remedies Limited Ramanathan Hariharan Company Secretary & Head- Legal INDOCO REMEDIES LIMITED e : Indoco House, 166, CST Road, Kalina,Santacr B), Mumbai 400 098. Teli+#91-22-26541851/55 Pax:+91-22-26520787E mail:८c ompliance.officer@indoco.com Website: www.indoco.com CIN:L85190MH1947PLC00591; = STATEMENT OF STANDALONE FINANCIAL RESULTS FOR ‘THE QUARTER AND HALF YEAR ENDED 30TH SEPTEMBER 2026 S.No. | Particulars += 30,09.2e 0n 2d 6e d f 30.e 06.= 2026 Qu 3a 0r t 0e 9r 2e 0n 2d 5e d e 30.Y 0e 9a .r 2e 0ne 2d 6e d | Hal 3f Y .0e 9a .r e 0n 2d 5e d Y 3e 1- a .r 3e .I n 2n d e 2L d 6a khs (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Audited) 1 | i me from Operations | (a) Revenue from Operations 43,806 40,812 ie 42,930 84,618 81,491 1,63,354 ;| Oक 1 Pि t0 o) व h े ae eO ं lt nr h IIe i ennr sn cc cO oo op mm me ee er a (ft 1ri +on 2mg OI pn ec ro am te i ons (Net) {atb) 44 55 ,1 ,, 61 53 65 05 19 23 44 10 ,, 38 49 48 47 75 44 44 ,,1 82, 02 1 58 62 42 88 76 ,1 ,, 00 94 05 43 56 98 88 43 8, 6 21 54 18 53 24 11 ,, 76 18 25 ,, ,, 56 92 70 65 17 43 (०) wC oh ra kn -L igo nl e s pm ra iS ot ns ge o i rr f n ei vs sa et sl no s tc o akc r- no ii den n : s - sttu rm ae dd e n ii ns -h te rd g eo ods, 8 3 1,,, 495 859 799 8 3, , 46 8 00 8 42 2 19 9, , 46 5 70 3 72 9 17 7 (, , 13 8 707 989 14, 70 2o 1e 2 |i ‘f P E PV( ( ( ( r r९ xo1) 21 3 o ot c)) f fa eO l i iV D pt t t‘ i eR th E n n pe / Be ixi a rs eop pe en ( fl na ecc La or aie ony c la sse h C t se e Io i ) & ss o tB t n B ee D s e mn xe a2 f se 5v n (o e d 5r [l +*eAa ) mp )Eomx xr e ctn ei pt z t aE itx oip noe ann l s e Ie x t p ee mn ss e a nd Tax (3-4) 41 5 34 2 39 2 1 (, ,, , ,, ,, 29 40 7 70 94 40 70 8 19 85 45 04 6 49 76 ) 41 1 91 99 221 (, ,, ,,,, , 47 377 820 8 15 231 076 5 2 26 42 555 4 ) 41 3 14 29 2 2 , ,, ,,, , 98 022 75 1 73 20 6 573 8 67 91 334 1 0 8 12 11 7 2358 4 S3 , ,( ,,, ,, 5 6 76 475 29 9 56 942 1 65 61 1 281 263 ) 8 ((21 6 1184 549 , ,,, ,,,, 6 880 253 3 66 1 5868 84 416 3324 57 )) 1,7 (53 1 125 089 ( ,, (, , ,, 8 14 25 8 63 6 43 85 926 71 620 003 )) 8 |[ | Tax Expenses - - - C MDu e Ar f Tr ee r n Cr rt e e d d it Adjustments (8 4 : 5 507 ) 1,0 : 35 46 (5= 2 29) 1 (, 4 -9 11 63 ) (5 -- 63) (8 :2 79 32 ) 9. || PP ro ot fa il t for E tx hep e pn es re is o d (7-8) 3,4 00 67 3 81 ,, 20 39 20 1( ,5 52 09 5) 111 ,, 24 99 57 (1,( 35 06 13 )) (( 55 68 61 )) 10. | Other ComprehensInicvomee 1 li1) s) he Im ncs a mt eh a tt a xw i al nl n vo et l ab te i nr ge c tol a ts his s ifi ie td e mto profit and loss ( 160 5) ( 160 5) ( 17 95) है (1 350 8) 1 (7 458 b 0 {lems that jay be reclassified to profit or loss - - 152 - 281 11 121 3. / TT[ {P1 oo a] tt i aa dI lln u c pCGo t or h Fe mr qp ur ie thC yex o n So m s hn p i a vr rr ee ee hl e Ca i ant n ps ii c tin at ov lgo e m (t eh F{i as I f cn o ec r o v i tt ame h lem e u ey e Rsa .r 2( /9 - + e1 a0 c) h ) 3 1, ,0( 8- 4 1 45 8 6) 8 1, ,1(- 8 84 45 7 6) 1 1, ,5( 85 63 47 29 5 ) 11, 1,2(- 8 09 40 5 6) p 1,( 89 l7 481 5) 1( ,1 4 8- 33 433 6) 14 1,08,073 3.32 8.92 1.63 12.24 (1.41) (0.61) 3132 8.92 1.63 12,23 (1.41) (0.61) he camara i | | inectinm gu d bi elt de d o nS t 27ti hda Ol co tne o bR ee rs ,u 2lt 0s 2 6f ,o r T hth ee SQ tu aa tr utt oe rr y a nd A udH ia tl of r s haYe var ee n ec xe pd re 3 s0 st eh d S ae np t Ue nm mb oe dr i, f i2 e0 d2 A6 u h da iv t e o pb ie ne in o nr e ov ni te hw ee sd e b uy n at uhe d iA tu ed di t S tc ao nm dm ai lt ot ne ee Fa in nad n ca ip ap lr o Rev se ud l tsv .y the Board of Director =Company at its 2 11161 vs ior corresponding previous periods have been restated / regrouped wherever necessary, to make them comparable, 3 j'The company has only one primary reportable segment of activity, namely, Pharmaceuticals i Net Sales and Income from Operations as per Secondary Segment (Geographica)) is as follows: (Rs. In Lakhs) Net Sales aud Income from Operations erended Quarteer ended | Quarter ended aended | Half Year ende d Year ended 30.09.2026 30.06.2026 30.09.2025 30.09.2026 30.09.2025 31.03.2026 (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Audited) = 24,304 22,775 24,735 47,079 46,990 89,413 i jWutside India 19,502 18,037 18,195 37539| 34,501 73,941 i | 1041 43,806 40,812 42,930) 84,618 81,491) 1,63,354 | 5 stanutory auditors of the company have carried out limited review of the financial results for the quarter ended 30th September, 2026, pee tional items Curing the quarter includes: on sale of the Company's property situated at Andheri (ast), Mumbai, amounting to Rs 3,663 Lakhs. The property was classified as eld for sale as at 31 March 2026 in accordance with Ind AS i1 . deration received Rs. 51 lakhs for grant to use exclusive, perpetual and irrevocable license rights in respect of trademarks of the company, ent of Assets and Liabilities BiIn Leakhs Larticulars As at 30.09.2026 ie As at 31.03.2026 | 1 (2020 5 | jfa} Property, Plent and Equipment | 10) Capital Workin Progress 66,807 3 । ile 2,394 2,349 | i 6,373 8,008 328 - | Ife gible Assets under Development 111 Right to Use of Asset 6,966 6,172 10,181 6,791 It 3) Financial Assets ॥ stinents | 16,362 15,975 8,949 5,056 | Einar ets 1,560 1,633 [1] Deferred ' sets (Net) 289 - (ij Other Non-Current Assets 8,982 8,808 Yolal - Non-Current Assets 1,29,191 1,25,138 2 |Current Assets (६) Inventories 31,339 32,183 (9) Financial Assets (i) investments 1,011 न (it) Trade Receivables 58,070 54,120 [11] Cash and uiva.ents 2,421 1,294 |1. G [५v )) LB oa an nk s Bala her Than (iii) above 705 706 458 456 { {vi} Other Financial Assets 3,619 3,578 I } Current Tax Assets (Net) (d) Other Current Assets 15,7- 142 ,, 51 53 86 (e) Assets Classified as held for Sale 452 2,341 ‘Total - Current Assets 1,13,861 1,11,372 Total - Assets 243,052 2,36,510 Hb) Our 1,19,130 1,081 ,, 08 74 36 | Total E 1,20,976 1,09,919 2 ‘Liabilities 1) |Non-Current Liabilities () Borrowin, 30,641 (ia) Lease Liabilities 6,505 | [1] Other Financial Liabilities 184 1 iC[ 0) DP er fo ev ris ri eo dn Ts a x Lia ilies (Net) 23 3, 14 56 78 11) Other '४0॥-( nt Liabilities 749 749 विदा - Non-Current Liabilities s 41,402 39,044 b) ilities al Liabilities | ine4 0,399 i (ia) Lease Liabilities 1,740 1,156 | (ii) Trade Payables | (A) Total Outstanding Dues of Micro Enterprises 6,822 8,184 | and Smajl Enterprises | (3) Total Outstanding Dues of Other than Micro 15,962 17,871 | Enterp) and Small Enterprises |। (b) (i Pl) r oO vt ih se ir on F si nancial Liabilities 1 40 ,, 50 00 11 z 4,041 | (ec) Other Cur [Showing first 8,000 characters — download PDF for full document]